AstraZeneca PLC Pink Sheet Forecast - Naive Prediction
| AZNCF Stock | USD 187.00 9.50 5.35% |
AstraZeneca Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of AstraZeneca PLC's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 27th of January 2026 the relative strength index (rsi) of AstraZeneca PLC's share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 54
Impartial
Oversold | Overbought |
Using AstraZeneca PLC hype-based prediction, you can estimate the value of AstraZeneca PLC from the perspective of AstraZeneca PLC response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of AstraZeneca PLC on the next trading day is expected to be 176.95 with a mean absolute deviation of 2.83 and the sum of the absolute errors of 175.24. AstraZeneca PLC after-hype prediction price | USD 187.43 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AstraZeneca |
AstraZeneca PLC Additional Predictive Modules
Most predictive techniques to examine AstraZeneca price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca using various technical indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
AstraZeneca PLC Naive Prediction Price Forecast For the 28th of January
Given 90 days horizon, the Naive Prediction forecasted value of AstraZeneca PLC on the next trading day is expected to be 176.95 with a mean absolute deviation of 2.83, mean absolute percentage error of 12.64, and the sum of the absolute errors of 175.24.Please note that although there have been many attempts to predict AstraZeneca Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that AstraZeneca PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
AstraZeneca PLC Pink Sheet Forecast Pattern
| Backtest AstraZeneca PLC | AstraZeneca PLC Price Prediction | Buy or Sell Advice |
AstraZeneca PLC Forecasted Value
In the context of forecasting AstraZeneca PLC's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. AstraZeneca PLC's downside and upside margins for the forecasting period are 174.74 and 179.17, respectively. We have considered AstraZeneca PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of AstraZeneca PLC pink sheet data series using in forecasting. Note that when a statistical model is used to represent AstraZeneca PLC pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.4853 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.8265 |
| MAPE | Mean absolute percentage error | 0.0156 |
| SAE | Sum of the absolute errors | 175.2415 |
Predictive Modules for AstraZeneca PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AstraZeneca PLC After-Hype Price Density Analysis
As far as predicting the price of AstraZeneca PLC at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AstraZeneca PLC or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of AstraZeneca PLC, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AstraZeneca PLC Estimiated After-Hype Price Volatility
In the context of predicting AstraZeneca PLC's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AstraZeneca PLC's historical news coverage. AstraZeneca PLC's after-hype downside and upside margins for the prediction period are 185.21 and 189.65, respectively. We have considered AstraZeneca PLC's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AstraZeneca PLC is very steady at this time. Analysis and calculation of next after-hype price of AstraZeneca PLC is based on 3 months time horizon.
AstraZeneca PLC Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as AstraZeneca PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AstraZeneca PLC backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AstraZeneca PLC, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 2.22 | 0.43 | 0.01 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
187.00 | 187.43 | 0.23 |
|
AstraZeneca PLC Hype Timeline
AstraZeneca PLC is presently traded for 187.00. The entity has historical hype elasticity of 0.43, and average elasticity to hype of competition of 0.01. AstraZeneca is forecasted to increase in value after the next headline, with the price projected to jump to 187.43 or above. The average volatility of media hype impact on the company the price is about 127.59%. The price rise on the next news is estimated to be 0.23%, whereas the daily expected return is presently at 0.25%. The volatility of related hype on AstraZeneca PLC is about 4352.94%, with the expected price after the next announcement by competition of 187.01. The company reported the revenue of 44.35 B. Net Income was 3.29 B with profit before overhead, payroll, taxes, and interest of 35.73 B. Assuming the 90 days horizon the next forecasted press release will be in about 3 days. Check out Historical Fundamental Analysis of AstraZeneca PLC to cross-verify your projections.AstraZeneca PLC Related Hype Analysis
Having access to credible news sources related to AstraZeneca PLC's direct competition is more important than ever and may enhance your ability to predict AstraZeneca PLC's future price movements. Getting to know how AstraZeneca PLC's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AstraZeneca PLC may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RHHVF | Roche Holding AG | (0.03) | 18 per month | 1.43 | 0.13 | 3.94 | (2.76) | 11.81 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.89 | 0.16 | 3.55 | (1.93) | 12.52 | |
| RHHBF | Roche Holding AG | 1.74 | 3 per month | 2.55 | 0.06 | 5.57 | (4.32) | 19.30 | |
| NVSEF | Novartis AG | 0.00 | 0 per month | 2.28 | 0.07 | 5.01 | (5.11) | 14.63 | |
| NONOF | Novo Nordisk AS | 0.00 | 0 per month | 2.53 | 0.06 | 6.71 | (4.28) | 15.55 | |
| SRTOY | Sartorius Stedim Biotech | 0.00 | 0 per month | 1.97 | (0.01) | 2.92 | (3.28) | 14.94 | |
| SNYNF | Sanofi | (1.20) | 28 per month | 0.00 | (0.09) | 2.83 | (3.28) | 8.58 | |
| FSNUY | Fresenius SE Co | 0.00 | 0 per month | 4.46 | (0) | 5.40 | (5.03) | 24.75 | |
| CHGCY | Chugai Pharmaceutical Co | 0.00 | 0 per month | 1.74 | 0.09 | 3.99 | (2.84) | 11.05 | |
| CHGCF | Chugai Pharmaceutical Co | 0.00 | 0 per month | 3.97 | 0.06 | 7.70 | (6.83) | 18.43 |
Other Forecasting Options for AstraZeneca PLC
For every potential investor in AstraZeneca, whether a beginner or expert, AstraZeneca PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AstraZeneca Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AstraZeneca. Basic forecasting techniques help filter out the noise by identifying AstraZeneca PLC's price trends.AstraZeneca PLC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AstraZeneca PLC pink sheet to make a market-neutral strategy. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AstraZeneca PLC Market Strength Events
Market strength indicators help investors to evaluate how AstraZeneca PLC pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC pink sheet market strength indicators, traders can identify AstraZeneca PLC entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 187.0 | |||
| Day Typical Price | 187.0 | |||
| Price Action Indicator | 4.75 | |||
| Period Momentum Indicator | 9.5 | |||
| Relative Strength Index | 54.13 |
AstraZeneca PLC Risk Indicators
The analysis of AstraZeneca PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AstraZeneca PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astrazeneca pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.57 | |||
| Semi Deviation | 1.72 | |||
| Standard Deviation | 2.15 | |||
| Variance | 4.62 | |||
| Downside Variance | 4.87 | |||
| Semi Variance | 2.97 | |||
| Expected Short fall | (1.80) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for AstraZeneca PLC
The number of cover stories for AstraZeneca PLC depends on current market conditions and AstraZeneca PLC's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AstraZeneca PLC is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AstraZeneca PLC's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
AstraZeneca PLC Short Properties
AstraZeneca PLC's future price predictability will typically decrease when AstraZeneca PLC's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AstraZeneca PLC often depends not only on the future outlook of the potential AstraZeneca PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AstraZeneca PLC's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 B | |
| Dividends Paid | -4.4 B | |
| Short Long Term Debt | 5.3 B |
Other Information on Investing in AstraZeneca Pink Sheet
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.